Do you have the same question? Follow this Question
Oct 01, 2025 - 04:57 AM
We’ve provided several answers to questions related to Amrix (Cyclobenzaprine Hydrochloride Extended-Release Capsules) , see some other helpful Q&A related to this product.
Question: What are the common drug-drug interactions with this product?
Answer: Interactions may occur with drugs such as bepridil, cisapride, and dronedarone, among others. Understanding potential interactions helps in avoiding adverse effects and optimizing treatment efficacy.
Question: What is the PubChem CID for this product?
Answer: The PubChem CID is 2895. PubChem CIDs allow easy access to chemical information, which is beneficial for scientific research and education regarding the compound's properties and effects.
Question: What is the chemical name of this product?
Answer: The chemical name is 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine hydrochloride. Understanding the chemical name can help in identifying the specific compound used and its related pharmacological properties.
Question: What are the common side effects of this product?
Answer: Common side effects may include dizziness, drowsiness, and dry mouth. Awareness of side effects helps users anticipate and manage them, enhancing the safety and comfort of the treatment.
Question: What is the usual dosage for this product?
Answer: The usual dosage is 15-30 mg taken by mouth once daily. Consistent daily dosing can lead to better management of symptoms and improved effectiveness of the treatment plan.
View all Amrix (Cyclobenzaprine Hydrochloride Extended-Release Capsules) Questions & Answers
